× Important note: Due to the end of funding, these reviews are no longer in living mode. We try to update them on a monthly basis.

meta|Evidence - COVID-19

Living meta-analysis and evidence synthesis of therapies for COVID19  

Member of the meta|Evidence galaxy

tutorial video
En     Fr

Our approach

RSS

       
Treament Trials   auto
deathsclinical improvementdeath or ventilation
0---
0---
2 0.55 [0.36; 0.84], 1 RCT, I2=0%
unassessable degree of certainty
1.29 [1.12; 1.49], 1 RCT, I2=0%
unassessable degree of certainty
-
1 2.00 [0.16; 24.66], 1 RCT, I2=0%
inconclusive result
--
1 0.87 [0.77; 0.98], 1 RCT, I2=0% conclusive
unassessable degree of certainty
- 0.90 [0.81; 0.99], 1 RCT, I2=0%
unassessable degree of certainty
0---
0---
0---
0 / 1 ---
1 / 2 1.52 [0.41; 5.62], 1 RCT, I2=0%
inconclusive result
1.06 [0.80; 1.41], 1 RCT, I2=0%
inconclusive result
0.83 [0.38; 1.81], 1 RCT, I2=0%
inconclusive result
0---
0---
0---

Statistically conclusive: statistically significant with a strict control of overall risk of type 1 error (statistically demonstrated), does not take into account the risk of bias; suggested: nominally statistically significant but without a strict control of overall risk of type 1 error; inconclusive: not nominally statistically significant

149
treatments
  718
studies with results
  1743
studies screend
  1629
references

This project is supported by a grant of the French Ministry of Health (Hospital Clinical Research Program, PHRC-N), Université de Lyon (UdL/Idex), and self-funded by Hospices Civils de Lyon, CNRS UMR5558 LBBE University Lyon-1.

     

- About - Our approach - Credits - RSS Made with in Lyon - Contact us - Privacy policy - Licence Creative Commons